|
| U.S. Brand
Names |
|
| Elase-Chloromycetin® Topical;
Elase®
Topical |

|
|
| Generic
Available |
|
|
No |

|
|
| Synonyms |
|
|
Desoxyribonuclease and Fibrinolysin |

|
|
| Pharmacological Index |
|
|
Enzyme |

|
|
| Use |
|
|
Debriding agent; cervicitis; and irrigating agent in infected
wounds |

|
|
| Pregnancy Risk
Factor |
|
|
C |

|
|
| Usual Dosage |
|
|
Ointment: 2-3 times/day
Wet dressing: 3-4 times/day |

|
|
| Administration |
|
|
Clean wound to remove debris before each application |

|
|
| Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
|
No information available to require special precautions |

|
|
| Dental Health:
Effects on Dental Treatment |
|
|
No effects or complications reported |

|
|
| Patient
Information |
|
|
For External Use Only |

|
|
| Dosage Forms |
|
|
Ointment, topical:
Elase®: Fibrinolysin 1 unit and desoxyribonuclease
666.6 units per g (10 g, 30 g)
Elase-Chloromycetin®: Fibrinolysin 1 unit and
desoxyribonuclease 666.6 units per g with chloramphenicol 10 mg per g (10 g, 30
g)
Powder, dry: Fibrinolysin 25 units and desoxyribonuclease 15,000 units per 30
g |

|
|
Copyright © 2007 Drugs Area
|